{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:14:00Z","timestamp":1726413240195},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00399-021-00751-w","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T13:02:49Z","timestamp":1617714169000},"page":"158-163","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Atrial fibrillation during pregnancy: a\u00a09-month period with limited options","Schwangerschaft und Vorhofflimmern: 9\u00a0Monate mit limitierten M\u00f6glichkeiten"],"prefix":"10.1007","volume":"32","author":[{"given":"Konstantinos","family":"Iliodromitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Kociszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harilaos","family":"Bogossian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"issue":"8","key":"751_CR1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh\u00a0SS, Havmoeller\u00a0R, Narayanan\u00a0K, Singh\u00a0D, Rienstra\u00a0M, Benjamin\u00a0EJ et\u00a0al (2014) Worldwide epidemiology of atrial fibrillation: a\u00a0global burden of disease 2010 study. Circulation 129(8):837\u2013847","journal-title":"Circulation"},{"key":"751_CR2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006350","author":"L Mou","year":"2018","unstructured":"Mou L, Norby FL, Chen LY, O\u2019Neal WT, Lewis TT, Loehr LR, Soliman EZ, Alonso A (2018) Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (atherosclerosis risk in communities). Circ Arrhythm Electrophysiol. https:\/\/doi.org\/10.1161\/CIRCEP.118.006350","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"751_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrcardio.2016.45","volume":"13","author":"D Ko","year":"2016","unstructured":"Ko\u00a0D, Rahman\u00a0F, Schnabel\u00a0RB, Yin\u00a0X, Benjamin\u00a0EJ, Christophersen\u00a0IE (2016) Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 13:321\u2013332","journal-title":"Nat Rev Cardiol"},{"key":"751_CR4","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1046\/j.1523-1755.1998.00217.x","volume":"54","author":"AB Chapman","year":"1998","unstructured":"Chapman\u00a0AB, Abraham\u00a0WT, Zamudio\u00a0S, Coffin\u00a0C, Merouani\u00a0A, Young\u00a0D, Johnson\u00a0A, Osorio\u00a0F, Goldberg\u00a0C, Moore\u00a0LG, Dahms\u00a0T, Schrier\u00a0RW (1998) Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 54:2056\u20132063","journal-title":"Kidney Int"},{"key":"751_CR5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/HJH.0000000000000090","volume":"32","author":"AA Mahendru","year":"2014","unstructured":"Mahendru\u00a0AA, Everett\u00a0TR, Wilkinson\u00a0IB, Lees\u00a0CC, McEniery\u00a0CM (2014) A longitudinal study of maternal cardiovascular function from preconception to the postpartum period. J\u00a0Hypertens 32:849\u2013856","journal-title":"J Hypertens"},{"key":"751_CR6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1172\/JCI103205","volume":"34","author":"RA Bader","year":"1955","unstructured":"Bader\u00a0RA, Bader\u00a0ME, Rose\u00a0DF, Braunwald\u00a0E (1955) Hemodynamics at rest and during exercise in normal pregnancy as studies by cardiac catheterization. J\u00a0Clin Invest 34:1524\u20131536","journal-title":"J Clin Invest"},{"issue":"pt 2","key":"751_CR7","first-page":"H1060","volume":"256","author":"SC Robson","year":"1989","unstructured":"Robson\u00a0SC, Hunter\u00a0S, Boys\u00a0RJ, Dunlop\u00a0W (1989) Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 256(pt 2):H1060\u2013H1065","journal-title":"Am J Physiol"},{"key":"751_CR8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/hrt.68.12.540","volume":"68","author":"S Hunter","year":"1992","unstructured":"Hunter\u00a0S, Robson\u00a0SC (1992) Adaptation of the maternal heart in pregnancy. Br Heart\u00a0J 68:540\u2013543","journal-title":"Br Heart J"},{"issue":"pt 15","key":"751_CR9","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1113\/jphysiol.2012.228262","volume":"590","author":"SS Jarvis","year":"2012","unstructured":"Jarvis\u00a0SS, Shibata\u00a0S, Bivens\u00a0TB, Okada\u00a0Y, Casey\u00a0BM, Levine\u00a0BD, Fu\u00a0Q (2012) Sympathetic activation during early pregnancy in humans. J\u00a0Physiol 590(pt 15):3535\u20133543","journal-title":"J Physiol"},{"key":"751_CR10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/hc4301.098253","volume":"104","author":"JP Greenwood","year":"2001","unstructured":"Greenwood\u00a0JP, Scott\u00a0EM, Stoker\u00a0JB, Walker\u00a0JJ, Mary\u00a0DA (2001) Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation 104:2200\u20132204","journal-title":"Circulation"},{"key":"751_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/0002-9378(72)90493-0","volume":"112","author":"LC Chesley","year":"1972","unstructured":"Chesley\u00a0LC (1972) Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 112:440\u2013450","journal-title":"Am J Obstet Gynecol"},{"key":"751_CR12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00000542-196507000-00004","volume":"26","author":"JA Pritchard","year":"1965","unstructured":"Pritchard\u00a0JA (1965) Changes in the blood volume during pregnancy and delivery. Anesthesiology 26:393\u2013399","journal-title":"Anesthesiology"},{"key":"751_CR13","first-page":"844","volume":"98","author":"JH Jepson","year":"1968","unstructured":"Jepson\u00a0JH (1968) Endocrine control of maternal and fetal erythropoiesis. Can Med Assoc\u00a0J 98:844\u2013847","journal-title":"Can Med Assoc J"},{"key":"751_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1471-0528.1987.tb02286.x","volume":"94","author":"SC Robson","year":"1987","unstructured":"Robson\u00a0SC, Hunter\u00a0S, Moore\u00a0M, Dunlop\u00a0W (1987) Haemodynamic changes during the puerperium: a\u00a0Doppler and M\u2011mode echocardiographic study. Br J Obstet Gynaecol 94:1028\u20131039","journal-title":"Br J Obstet Gynaecol"},{"key":"751_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1152\/japplphysiol.00549.2012","volume":"113","author":"S Umar","year":"2012","unstructured":"Umar\u00a0S, Nadadur\u00a0R, Iorga\u00a0A, Amjedi\u00a0M, Matori\u00a0H, Eghbali\u00a0M (2012) Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum. J\u00a0Appl Physiol (1985) 113:1253\u20131259","journal-title":"J Appl Physiol (1985)"},{"key":"751_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-16-1","volume":"16","author":"RA Ducas","year":"2014","unstructured":"Ducas\u00a0RA, Elliott\u00a0JE, Melnyk\u00a0SF, Premecz\u00a0S, daSilva\u00a0M, Cleverley\u00a0K, Wtorek\u00a0P, Mackenzie\u00a0GS, Helewa\u00a0ME, Jassal\u00a0DS (2014) Cardiovascular magnetic resonance in pregnancy: insights from the Cardiac Hemodynamic Imaging and Remodeling in Pregnancy (CHIRP) study. J\u00a0Cardiovasc Magn Reson 16:1","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"751_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00360-1","volume":"88","author":"RM Gowda","year":"2003","unstructured":"Gowda\u00a0RM, Punukollu\u00a0G, Khan\u00a0IA, Wilbur\u00a0SL, Navarro\u00a0VS, Vasavada\u00a0BC, Sacchi\u00a0TJ (2003) Lone atrial fibrillation during pregnancy. Int J Cardiol 88(1):123\u2013124","journal-title":"Int J Cardiol"},{"key":"751_CR18","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof\u00a0P, Benussi\u00a0S, Kotecha\u00a0D et\u00a0al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart\u00a0J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"751_CR19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7326\/M18-0338","volume":"169","author":"BT Bateman","year":"2018","unstructured":"Bateman\u00a0BT, Heide-Jorgensen\u00a0U, Einarsdottir\u00a0K et al (2018) beta-blocker use in pregnancy and the risk for congenital malformations: an international cohort study. Ann Intern Med 169:665\u2013673","journal-title":"Ann Intern Med"},{"key":"751_CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40264-017-0627-x","volume":"41","author":"JEH Bergman","year":"2018","unstructured":"Bergman\u00a0JEH, Lutke\u00a0LR, Gans\u00a0ROB et al (2018) Beta-blocker use in pregnancy and risk of specific congenital anomalies: a European case-malformed control study. Drug Saf 41:415\u2013427","journal-title":"Drug Saf"},{"key":"751_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jamainternmed.2017.0608","volume":"177","author":"L Duan","year":"2017","unstructured":"Duan\u00a0L, Ng\u00a0A, Chen\u00a0W et al (2017) beta-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med 177:885\u2013887","journal-title":"JAMA Intern Med"},{"key":"751_CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.111.00833","volume":"62","author":"MY Yakoob","year":"2013","unstructured":"Yakoob\u00a0MY, Bateman\u00a0BT, Ho\u00a0E et al (2013) The risk of congenital malformations associated with exposure to beta-blockers early in pregnancy: a\u00a0meta-analysis. Hypertension 62:375\u2013381","journal-title":"Hypertension"},{"key":"751_CR23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9378(79)90436-8","volume":"135","author":"SC Pruyn","year":"1979","unstructured":"Pruyn\u00a0SC, Phelan\u00a0JP, Buchanan\u00a0GC (1979) Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol 135:485\u2013489","journal-title":"Am J Obstet Gynecol"},{"key":"751_CR24","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jch.13397","volume":"20","author":"L Duan","year":"2018","unstructured":"Duan\u00a0L, Ng\u00a0A, Chen\u00a0W, Spencer\u00a0HT, Lee\u00a0MS (2018) Beta-blocker subtypes and risk of low birth weight in newborns. J\u00a0Clin Hypertens (Greenwich) 20:1603\u20131609","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"751_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0895-7061(99)00031-X","volume":"12","author":"C Lydakis","year":"1999","unstructured":"Lydakis\u00a0C, Lip\u00a0GY, Beevers\u00a0M, Beevers\u00a0DG (1999) Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 12:541\u2013547","journal-title":"Am J Hypertens"},{"key":"751_CR26","first-page":"746","volume":"58","author":"F Alabdulrazzaq","year":"2012","unstructured":"Alabdulrazzaq\u00a0F, Koren\u00a0G (2012) Fetal safety of calcium channel blockers. Can Fam Physician 58:746\u2013747","journal-title":"Can Fam Physician"},{"key":"751_CR27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1586\/14779072.2015.1107476","volume":"13","author":"JM Wright","year":"2015","unstructured":"Wright\u00a0JM, Page\u00a0RL, Field\u00a0ME (2015) Antiarrhythmic drugs in pregnancy. Expert Rev Cardiovasc Ther 13:1433\u20131444","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"751_CR28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9378(96)70307-1","volume":"174","author":"LA Magee","year":"1996","unstructured":"Magee\u00a0LA, Schick\u00a0B, Donnenfeld\u00a0AE, Sage\u00a0SR, Conover\u00a0B, Cook\u00a0L, McElhatton\u00a0PR, Schmidt\u00a0MA, Koren\u00a0G (1996) The safety of calcium channel blockers in human pregnancy: a\u00a0prospective, multicenter cohort study. Am J Obstet Gynecol 174(3):823\u2013828","journal-title":"Am J Obstet Gynecol"},{"key":"751_CR29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/pds.2068","volume":"20","author":"RL Davis","year":"2011","unstructured":"Davis\u00a0RL, Eastman\u00a0D, McPhillips\u00a0H et al (2011) Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf 20:138\u2013145","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"751_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart\u00a0J"},{"key":"751_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-98-4-487","volume":"98","author":"HH Rotmensch","year":"1983","unstructured":"Rotmensch\u00a0HH, Elkayam\u00a0U, Frishman\u00a0W (1983) Antiarrhythmic drug therapy during pregnancy. Ann Intern Med 98:487\u2013497","journal-title":"Ann Intern Med"},{"key":"751_CR32","doi-asserted-by":"crossref","first-page":"58i","DOI":"10.1016\/S0002-9149(98)00473-1","volume":"82","author":"T Chow","year":"1998","unstructured":"Chow\u00a0T, Galvin\u00a0J, McGovern\u00a0B (1998) Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 82:58i\u201362i","journal-title":"Am J Cardiol"},{"key":"751_CR33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/pd.5144","volume":"37","author":"GD Hill","year":"2017","unstructured":"Hill\u00a0GD, Kovach\u00a0JR, Saudek\u00a0DE et al (2017) Transplacental treatment of fetal tachycardia: a systematic review and meta-analysis. Prenat Diagn 37:1076\u20131083","journal-title":"Prenat Diagn"},{"key":"751_CR34","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1586\/14779072.2015.1107476","volume":"13","author":"JM Wright","year":"2015","unstructured":"Wright\u00a0JM, Page\u00a0RL, Field\u00a0ME (2015) Antiarrhythmic drugs in pregnancy. Expert Rev Cardiovasc Ther 13:1433\u20131444","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"751_CR35","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1161\/01.CIR.101.23.2721","volume":"101","author":"MA Oudijk","year":"2000","unstructured":"Oudijk\u00a0MA, Michon\u00a0MM, Kleinman\u00a0CS et\u00a0al (2000) Sotalol in the treatment of fetal dysrhythmias. Circulation 101:2721\u20132726","journal-title":"Circulation"},{"key":"751_CR36","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","volume":"172","author":"LA Magee","year":"1995","unstructured":"Magee\u00a0LA, Downar\u00a0E, Sermer\u00a0M et\u00a0al (1995) Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 172:1307\u20131311","journal-title":"Am J Obstet Gynecol"},{"key":"751_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0002-9149(94)90242-9","volume":"73","author":"M Ovadia","year":"1994","unstructured":"Ovadia\u00a0M, Brito\u00a0M, Hoyer\u00a0GL, Marcus\u00a0FI (1994) Human experience with amiodarone in the embryonic period. Am J Cardiol 73:316\u2013317","journal-title":"Am J Cardiol"},{"issue":"2","key":"751_CR38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","volume":"16","author":"KA Bremme","year":"2003","unstructured":"Bremme\u00a0KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16(2):153\u2013168","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2 Suppl","key":"751_CR39","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","volume":"141","author":"SM Bates","year":"2012","unstructured":"Bates\u00a0SM, Greer\u00a0IA, Middeldorp\u00a0S, Veenstra\u00a0DL, Prabulos\u00a0AM, Vandvik\u00a0PO (2012) VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e691S\u2013e736S","journal-title":"Chest"},{"issue":"2","key":"751_CR40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejogrb.2012.05.010","volume":"163","author":"PJ Galambosi","year":"2012","unstructured":"Galambosi\u00a0PJ, Kaaja\u00a0RJ, Stefanovic\u00a0V, Ulander\u00a0VM (2012) Safety of low-molecular-weight heparin during pregnancy: a\u00a0retrospective controlled cohort study. Eur J Obstet Gynecol Reprod Biol 163(2):154\u2013159","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"751_CR41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaci.2013.02.047","volume":"132","author":"M Schindewolf","year":"2013","unstructured":"Schindewolf\u00a0M, Gobst\u00a0C, Kroll\u00a0H, Recke\u00a0A, Louwen\u00a0F, Wolter\u00a0M et al (2013) High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy. J\u00a0Allergy Clin Immunol 132(1):131\u2013139","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"751_CR42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jth.12085","volume":"11","author":"E Romualdi","year":"2013","unstructured":"Romualdi\u00a0E, Dentali\u00a0F, Rancan\u00a0E, Squizzato\u00a0A, Steidl\u00a0L, Middeldorp\u00a0S et al (2013) Anticoagulant therapy for venous thromboembolism during pregnancy: a\u00a0systematic review and a\u00a0meta-analysis of the literature. J\u00a0Thromb Haemost 11(2):270\u2013281","journal-title":"J Thromb Haemost"},{"issue":"2","key":"751_CR43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/187152571302151217124957","volume":"13","author":"RK Chaudhary","year":"2015","unstructured":"Chaudhary\u00a0RK, Nepal\u00a0C, Khanal\u00a0N, Pathak\u00a0R, Giri\u00a0S, Bhatt\u00a0VR (2015) Management and outcome of heparin-induced thrombocytopenia in pregnancy: a systematic review. Cardiovasc Hematol Agents Med Chem 13(2):92\u201397","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"1","key":"751_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1160\/TH04-06-0345","volume":"93","author":"E Lindhoff-Last","year":"2005","unstructured":"Lindhoff-Last\u00a0E, Kreutzenbeck\u00a0HJ, Magnani\u00a0HN (2005) Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost 93(1):63\u201369","journal-title":"Thromb Haemost"},{"issue":"6","key":"751_CR45","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1651-2227.1977.tb07981.x","volume":"66","author":"KO Raivio","year":"1977","unstructured":"Raivio\u00a0KO, Ikonen\u00a0E, Saarikoski\u00a0S (1977) Fetal risks due to warfarin therapy during pregnancy. Acta Paediatr Scand 66(6):735\u2013739","journal-title":"Acta Paediatr Scand"},{"issue":"6","key":"751_CR46","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0735-1097(99)00044-3","volume":"33","author":"N Vitale","year":"1999","unstructured":"Vitale\u00a0N, De Feo\u00a0M, De Santo\u00a0LS, Pollice\u00a0A, Tedesco\u00a0N, Cotrufo\u00a0M (1999) Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J\u00a0Am Coll Cardiol 33(6):1637\u20131641","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"751_CR47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/021849230701500609","volume":"15","author":"AJ Khamooshi","year":"2007","unstructured":"Khamooshi\u00a0AJ, Kashfi\u00a0F, Hoseini\u00a0S, Tabatabaei\u00a0MB, Javadpour\u00a0H, Noohi\u00a0F (2007) Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer? Asian Cardiovasc Thorac Ann 15(6):493\u2013496","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"7","key":"751_CR48","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/jth.13353","volume":"14","author":"P Bapat","year":"2016","unstructured":"Bapat\u00a0P, Pinto\u00a0LS, Lubetsky\u00a0A, Aleksa\u00a0K, Berger\u00a0H, Koren\u00a0G et\u00a0al (2016) Examining the transplacental passage of apixaban using the dually perfused human placenta. J\u00a0Thromb Haemost 14(7):1436\u20131441","journal-title":"J Thromb Haemost"},{"issue":"5","key":"751_CR49","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2015.06.065","volume":"213","author":"P Bapat","year":"2015","unstructured":"Bapat\u00a0P, Pinto\u00a0LS, Lubetsky\u00a0A, Berger\u00a0H, Koren\u00a0G (2015) Rivaroxaban transfer across the dually perfused isolated human placental cotyledon. Am J Obstet Gynecol 213(5):710.e1\u2013710.e6","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"751_CR50","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0000000000000277","volume":"123","author":"P Bapat","year":"2014","unstructured":"Bapat\u00a0P, Kedar\u00a0R, Lubetsky\u00a0A, Matlow\u00a0JN, Aleksa\u00a0K, Berger\u00a0H et\u00a0al (2014) Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta. Obstet Gynecol 123(6):1256\u20131261","journal-title":"Obstet Gynecol"},{"issue":"5","key":"751_CR51","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/AOG.0000000000003220","volume":"133","author":"LD Pacheco","year":"2019","unstructured":"Pacheco\u00a0LD, Hankins\u00a0GDV, Saad\u00a0AF, Saade\u00a0GR (2019) Acute management of ischemic stroke during pregnancy. Obstet Gynecol 133(5):933\u2013939","journal-title":"Obstet Gynecol"},{"issue":"12","key":"751_CR52","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers\u00a0WJ, Rabinstein\u00a0AA, Ackerson\u00a0T, Adeoye\u00a0OM, Bambakidis\u00a0NC, Becker\u00a0K, Biller\u00a0J, Brown\u00a0M, Demaerschalk\u00a0BM, Hoh\u00a0B, Jauch\u00a0EC, Kidwell\u00a0CS, Leslie-Mazwi\u00a0TM, Ovbiagele\u00a0B, Scott\u00a0PA, Sheth\u00a0KN, Southerland\u00a0AM, Summers\u00a0DV, Tirschwell\u00a0DL (2019) Guidelines for the early management of patients with acute Ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50(12):e344\u2013e418","journal-title":"Stroke"},{"issue":"11","key":"751_CR53","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.19102\/icrm.2020.111105","volume":"11","author":"PC Zei","year":"2020","unstructured":"Zei\u00a0PC, Quadros\u00a0KK, Clopton\u00a0P, Thosani\u00a0A, Ferguson\u00a0J, Brodt\u00a0C, O\u2019Riordan\u00a0G, Ramsis\u00a0M, Mitra\u00a0R, Baykaner\u00a0T (2020) Safety and efficacy of minimal- versus zero-fluoroscopy radiofrequency catheter ablation for atrial fibrillation: a multicenter, prospective study. J\u00a0Innov Card Rhythm Manag 11(11):4281\u20134291","journal-title":"J Innov Card Rhythm Manag"},{"issue":"12","key":"751_CR54","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/pace.13819","volume":"42","author":"MM Li","year":"2019","unstructured":"Li\u00a0MM, Sang\u00a0CH, Jiang\u00a0CX, Guo\u00a0XY, Li\u00a0SN, Wang\u00a0W, Zhao\u00a0X, Tang\u00a0RB, Long\u00a0DY, Gao\u00a0H, Dong\u00a0JZ, Du\u00a0X, Ma\u00a0CS (2019) Maternal arrhythmia in structurally normal heart: prevalence and feasibility of catheter ablation without fluoroscopy. Pacing Clin Electrophysiol 42(12):1566\u20131572","journal-title":"Pacing Clin Electrophysiol"},{"issue":"6","key":"751_CR55","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/jce.12675","volume":"26","author":"K Driver","year":"2015","unstructured":"Driver\u00a0K, Chisholm\u00a0CA, Darby\u00a0AE, Malhotra\u00a0R, Dimarco\u00a0JP, Ferguson\u00a0JD (2015) Catheter ablation of arrhythmia during pregnancy. J\u00a0Cardiovasc Electrophysiol 26(6):698\u2013702","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00751-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-021-00751-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-021-00751-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T12:08:20Z","timestamp":1622462900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-021-00751-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1007\/s00399-021-00751-w","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"type":"print","value":"0938-7412"},{"type":"electronic","value":"1435-1544"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.\u00a0Iliodromitis, J.\u00a0Kociszewski and H.\u00a0Bogossian declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were performed in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}